Brilaroxazine
id:
brilaroxazine-186-17820276
title:
Brilaroxazine
text:
Brilaroxazine, also known as oxaripiprazole, is an investigational atypical antipsychotic which is under development by Reviva Pharmaceuticals for the treatment of neuropsychiatric and inflammatory disorders. It has currently completed the first of two phase III clinical trials for schizophrenia. Reviva Pharmaceuticals also intends to investigate brilaroxazine for the treatment of bipolar disorder, major depressive disorder, attention deficit hyperactivity disorder (ADHD), irritability in autism
brand slug:
wiki
category slug:
encyclopedia
description:
Experimental atypical antipsycotic
original url:
https://en.wikipedia.org/wiki/Brilaroxazine
date created:
2015-05-20T03:18:30Z
date modified:
2024-09-08T08:19:47Z
main entity:
{"identifier":"Q25098912","url":"https://www.wikidata.org/entity/Q25098912"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/e/e3/Brilaroxazine.svg","width":2215,"height":725}
fields total:
13
integrity:
16